Study Type definition

Study Type means the nature of the investigation or investigational use for which clinical trial information is being submitted, e.g., interventional, observational.
Sample 1Sample 2Sample 3
Study Type. Installation of a 25 Mar Shunt Capacitor Bank (TP-2008-05) Requestor: PNM Location: Yah-Ta- Hey Switching Station
Sample 1Sample 2
Study Type. Red Mesa Switching Station (TP-2010-01) Requestor: PNM
Sample 1Sample 2

Examples of Study Type in a sentence

  • Low Income Hours of Use and Heating Study Type of Study: Impact EvaluationEvaluation Conducted by: The Cadmus Group, Inc.Date Evaluation Completed: 6/28/2013 Evaluation Objective and High Level Findings: The objective of the study is to assess lighting hours of use (HOU) and the prevalence of secondary heating among low income customers.

  • INCITS project types are defined below.• Study (Type S) Project: Study projects are to determine the feasibility and need for a development project which has been proposed to INCITS.

  • Level of Education:Secondary Education Bachelor MasterOther Course of Study Type of Education: Preparatory training BachelorSeat of Educational Institution:3.

  • This data element is only applicable for Expanded Access records (see Expanded Access under Study Type).

  • Phase I and II engineering services are required for the preparation of a Structure Geotechnical Report, Wall Type Study, Type, Size and Location (TS&L) and final contract plans, specifications and cost estimates for retaining walls located along Illinois Route 29 from Gardner Lane in Peoria Heights to the McClugage Bridge in Peoria.

  • STAFFOriginal Study : Funded/Not Funded Any Other Study Type (Please Specify) :IIIPROTOCOL CHECKLIST (Tick the relevant boxes) A.

  • Acute Toxicity Profile of Ammonium Thiosulfate Guideline Number Study Type MRID(s) Results Toxicity Category polypnea and dyspnea, languid behavior, hunched appearance, prostration and tremors, rhinorrhea, chromodacryorrhea, and salivation.

  • In the screening phase, phase ii) retrieved citations were screened for possible inclusion based on ‘title and abstract’ using the Participants, Exposure, Outcomes, Study Type (PEOS) criteria for guidance.

  • Study Type :Interventional (Clinical Trial)Estimated Enrollment :960 participants (Globally) as per US Trial Registry720 participants (Globally) as per application & 240 participants in Pakistan.Allocation:RandomizedIntervention Model:Parallel AssignmentMasking:None (Open label)Primary Purpose:Treatment Official Title: Effectiveness of Novel Approaches to Radical Cure with Tafenoquine and Primaquine - a Randomized Controlled Trial in P.

  • All traffic count data required for the purpose of this study will either be provided by the DEPARTMENT or will be obtained by the CONSULTANT under Study Type IV.


More Definitions of Study Type

Study Type. Rio Puerco Expansion (TP-2008-01) Requestor: PNM
Sample 1Sample 2
Study Type. Expansion/Upgrade of the Xxxxxxx 115 kV Station (TP-2008-07) Requestor: PNM Study Type: Xxxxxxx Substation (TP-2008-09) Requestor: PNM
Sample 1Sample 2
Study Type. A Single Dose Pharmacokinetic Study of Recombinant Human Growth Factor (FGF-1) in Rats
Sample 1

Related to Study Type

  • Prop Type Sr Lien: Orig Amount: P&&I: Cr. Score: Sevicer Loan Prod Code: Rem Term: Occp Code: Appr Value: Note Date: Debt Ratio: City Stat Zip Purpose: Curr Rate: CLTV: Prin Bal: Maturity Date: Lien Pos: 8310314 180 14 $199,736.00 $64,000.00 $757.84 689 0301135240 6 179 1 $211,060.00 04/10/2002 44 York PA 17402 02 11.750 125 $64,000.00 04/10/2017 2 8310320 180 14 $49,966.51 $49,966.51 $624.00 665 0301144713 6 179 1 $152,000.00 04/19/2002 44 Northfield MN 55057 02 12.750 66 $49,779.71 04/24/2017 2 8310324 240 14 $164,190.55 $50,000.00 $612.71 670 0301131181 9 239 1 $185,000.00 04/17/2002 32 utica NE 68456 02 13.750 116 $50,000.00 04/29/2022 2 8310326 180 14 $130,537.00 $50,000.00 $653.32 673 0301135828 6 179 1 $165,650.00 04/25/2002 33 Mount Juliet TN 37122 02 13.630 109 $50,000.00 04/30/2017 2 8310340 300 14 $94,081.00 $27,500.00 $303.96 734 0301114781 8 300 1 $103,000.00 05/03/2002 38 COCOA FL 32927 02 12.700 119 $27,487.08 05/08/2027 2 8310346 180 14 $53,617.53 $30,000.00 $362.47 696 0301107280 6 179 1 $75,000.00 04/12/2002 21 pierceton IN 46562 02 12.130 112 $29,940.66 04/24/2017 2 8310350 180 14 $36,553.00 $35,000.00 $419.83 695 0301125332 6 179 1 $58,000.00 04/18/2002 17 WICHITA KS 67211 02 11.990 124 $35,000.00 04/23/2017 2 8310356 120 14 $135,089.00 $60,000.00 $830.75 698 0301117271 5 119 1 $170,000.00 04/24/2002 35 Lexington KY 40503 02 11.130 115 $60,000.00 04/29/2012 2 8310360 180 14 $189,663.00 $31,000.00 $423.31 655 0301107199 6 179 1 $180,000.00 04/15/2002 27 Landover MD 20785 02 14.500 123 $30,915.98 04/19/2017 2 8310380 180 14 $91,959.46 $35,000.00 $501.90 640 0301116232 6 179 1 $111,000.00 04/17/2002 45 norman OK 73071 02 15.500 115 $34,950.18 04/23/2017 2 8310382 181 14 $137,148.00 $38,000.00 $417.12 773 0301131132 6 180 1 $147,000.00 04/16/2002 38 apache junction AZ 85220 02 10.380 120 $38,000.00 05/06/2017 2 8310404 181 14 $138,360.00 $34,200.00 $469.91 671 0301121828 6 180 1 $139,000.00 04/30/2002 50 BATTLE GROUND WA 98604 02 14.630 125 $34,146.90 05/06/2017 2 8310408 301 16 $246,163.93 $33,500.00 $346.66 664 0301116125 8 300 1 $259,900.00 04/05/2002 44 rancho santa margarita CA 92688 02 11.750 108 $33,481.36 05/24/2027 2 8310412 180 14 $131,860.00 $45,600.00 $500.53 718 0301117909 6 179 1 $142,500.00 04/24/2002 40 Eagle Point OR 97524 02 10.380 125 $45,493.72 04/29/2017 2 8310414 240 14 $212,967.02 $26,803.79 $323.62 715 0301145686 9 239 1 $236,035.00 04/22/2002 50 Brooklyn NY 11234 02 13.500 102 $26,803.79 04/26/2022 2 8310424 180 14 $99,740.00 $35,000.00 $408.87 691 0301119814 6 179 1 $131,000.00 04/23/2002 30 Maurertown VA 22644 02 11.500 103 $35,000.00 04/29/2017 2 8310434 180 14 $171,255.00 $45,600.00 $509.73 720 0301120051 6 179 1 $174,000.00 04/24/2002 37 Coventry CT 06238 02 10.700 125 $45,600.00 04/29/2017 2 8310436 180 14 $169,972.55 $41,328.05 $620.00 667 0301144986 6 179 1 $183,734.00 04/18/2002 45 Monroe WA 98272 02 16.450 116 $41,210.95 04/23/2017 2 8310444 180 14 $68,962.00 $63,700.00 $699.21 702 0301119954 6 179 1 $108,000.00 04/24/2002 46 Phoenix AZ 85019 02 10.380 123 $63,700.00 04/29/2017 2 8310448 181 14 $179,000.00 $48,000.00 $597.87 727 0301125282 6 180 1 $190,000.00 04/26/2002 44 TOPEKA KS 66605 01 12.700 120 $47,402.13 05/02/2017 2 8310450 180 14 $127,190.00 $40,300.00 $442.36 730 0301122222 6 179 1 $138,000.00 04/25/2002 28 Gordonsville VA 22942 02 10.380 122 $40,206.07 04/30/2017 2

  • engine type means a category of engines which do not differ in essential engine characteristics.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • product type means any of the following:

  • Protocol means, in respect of any category of object and associated rights to which this Convention applies, the Protocol in respect of that category of object and associated rights;

  • Phase 3 means the period commencing on the day after the Phase 2 implementation date and ending on the Phase 3 implementation date (as defined below).

  • License Type means the identification of whether the license for a Software Product is for a Perpetual Term or Subscription Term as specified in the Quote.

  • Phase 1 Trial means, with respect to a Product, a human clinical trial that is intended to initially evaluate the safety, metabolism and pharmacokinetics of such Product that would otherwise satisfy the requirements of 21 C.F.R. 312.21(a) or an equivalent clinical trial in a country other than the United States.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Phase 1 means the phase of the ATP comprised of: (1) improvements to the State Street Substation; (2) construction of the Proposed Line; (3) the rebuilding of NYSEG’s existing Lines 971 and 000 xxxxx xx Xxxxxxxx Xxxx xx the NYSEG ROW to allow for construction of the Proposed Line as intended; (4) improvements to the Elbridge Substation to accept the Proposed Line; and (5) National Grid’s conveyance to NYSEG of the NYSEG Acquired ROW and such other land interests as contemplated by the Purchase and Sale Agreement.

  • Tests after Completion means the tests (if any) which are specified in the Contract and which are carried out in accordance with the Specification after the Works or a Section (as the case may be) are taken over by the Procuring Entity.

  • Genetic testing means an analysis of genetic markers to exclude or identify a man as the father or a woman as the mother of a child. The term includes an analysis of one or a combination of the following:

  • Treatability study means a study in which a hazardous waste is subjected to a treatment process to determine: (1) Whether the waste is amenable to the treatment process, (2) what pretreatment (if any) is required, (3) the optimal process conditions needed to achieve the desired treatment, (4) the efficiency of a treatment process for a specific waste or wastes, or (5) the characteristics and volumes of residuals from a particular treatment process. Also included in this definition for the purpose of the § 261.4 (e) and (f) exemptions are liner compatibility, corrosion, and other material compatibility studies and toxicological and health effects studies. A “treatability study” is not a means to commercially treat or dispose of hazardous waste.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase II Trial means a clinical trial of a Licensed Product, designated as a Phase II Trial and the principal purpose of which is to make a preliminary determination that such Licensed Product is safe and active in a patient population for its intended use and is designed to obtain sufficient information about such Licensed Product’s efficacy to permit the design of a Phase III Trial(s), and generally consistent with 21 CFR § 312.21(b). For purposes of this definition, Phase II trial shall specifically exclude expansion cohorts from Phase I Trial(s).

  • Timeline means the list of critical dates and actions included in the Introductory Materials.

  • Phase 1 Clinical Trial means a human clinical trial of a Licensed Product that would satisfy the requirements of 21 C.F.R. 312.21(a) or corresponding foreign regulations.

  • Study Completion means the database for the Study has been locked and all Essential Documents have been provided to the Sponsor, including a copy of the letter from the Reviewing HREC acknowledging receipt of the final report and/or closure letter from the Principal Investigator.

  • Selection Criteria means and includes all of the requirements, considerations,

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase III means human clinical trials, the principal purpose of which is to establish substantial evidence of both safety and efficacy in patients with the disease or condition being studied, as more fully defined in 21 C.F.R. §312.21(c) or similar clinical study in a country other than the United States. Phase III shall also include any other human clinical trial intended to serve as a pivotal trial to support the submission of an application for regulatory approval.

  • Screening means the process to determine whether the person seeking assistance needs further comprehensive assessment.

  • Clinical review criteria means the written screening procedures, decision abstracts, clinical protocols, and practice guidelines used by a health carrier to determine the necessity and appropriateness of health care services.

  • Risk assessment means a programme to determine any risk associated with any hazard at a construction site , in order to identify the steps needed to be taken to remove, reduce or control such hazard;

  • Acceptance Testing mean the tests, reviews and other activities that are performed by or on behalf of Agency to determine whether the Deliverables meet the Acceptance Criteria or otherwise satisfy the Agency, as determined by the Agency in its sole discretion.